Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Moderna Increases Minimum Supply Of Coronavirus Vaccine Doses For 2021

Company Still Anticipates Up To 1 Billion Doses

Executive Summary

The company’s announcement that it would supply at least 600 million doses of mRNA-1273 came as US vaccination rates have fallen far short of expectations.

You may also be interested in...



A Commercial-Stage Moderna Debuts At J.P. Morgan

Moderna has received $2.8bn for advance purchase agreements for its COVID-19 vaccine, with much more to follow. Management outlined some initial financial updates for investors.

Moderna Implements More Expansive Employee COVID-19 Vaccination Program Than Pfizer

Moderna will give its coronavirus vaccine to employees immediately, while Pfizer will wait until workers are eligible under prioritization guidelines.

Coronavirus Update: Moderna Secures Third Approval In Israel, World Leader In COVID-19 Vaccinations

Moderna has just secured its third global authorization for its COVID-19 vaccination in Israel, while the European Medicines Agency's review has been delayed.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

GB140150

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel